Stent

건강하고 행복한 삶을 만들어갑니다.

BioMime

Overview

Stent Architecture

Cobalt chromium (L605) platform with 65µm strut thickness.

Hybrid cell design comprising of an intelligent mix of open and close cells resulting in excellent radial strength with a high flexibility.

0.29% foreshortening.

Unique strut width variability that ensure a > 3% recoil and 0.29% foreshortening.

Special electro-polishing technique eliminates surface nickel oxides.

Low injury Design – Morphology Mediated Expansion™

Conventional edge-flaring stent designs allow the stent to dog-bone during deployment.

This dog-boning coupled with balloon overhang may cause edge injury.

BioMime has struts with design variability which results in morphology mediated expansionTM, having a propensity to minimize stent edge injury.

Excellent Side Branch Access

The area of the largest circle circumscribable in the cell of the stent expanded to the nominal diameter: Tc = 0.71 mm2.

Drug - Sirolimus

Sirolimus acts on the common final pathway of cell division cycle without exceptional risk of necrosis induction.

Low drug loading of 1.25µgm/mm2 of Sirolimus.

Drug elution time of 30 days.

BioPoly™

Cobalt chromium (L605) platform with 65µm strut thickness.

Hybrid cell design comprising of an intelligent mix of open and close cells resulting in excellent radial strength with a high flexibility.

0.29% foreshortening.

Unique strut width variability that ensure a <3% recoil and 0.29% foreshortening.

Special electro-polishing technique eliminates surface nickel oxides.

BioMime Coating integrity

Meril’s validated coating technique ensures uniformity of coating on both abluminal and adluminal surfaces and around the stent edges

Best-in-Class Drug Eluting Stent

SEM picture of BIOMIME endothelialisation

YOU WILL HAVE RESULTS LIKE THESE!

Complete and uniform endothelialisation, observed in porcine coronary artery model.
At 28 or at 90 days, no significant differences were found in any histomorphometric parameters of lumen or neointimal
hyperplasia (p > 0.05) between BIOMIME and Cypher in a pre-clinical porcine coronary artery model.